Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

80
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
80
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

81
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
Nephrons01:10

Nephrons

2.3K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.3K
Renal Corpuscle01:20

Renal Corpuscle

1.9K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.9K
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

163
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
163
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LATAM-AKID registry: an international multicentre, observational study of acute kidney injury requiring dialysis in Latin America.

BMJ open·2026
Same author

Renal Resistive Index in Severe Preeclampsia: Correlation With Glomerular Filtration Rate and Diagnostic Accuracy for Acute Kidney Injury.

International journal of nephrology·2026
Same author

Impact of hemoglobin increase in patients with acute kidney injury and severe anemia on major adverse kidney events.

Renal failure·2026
Same author

Prediction of acute kidney injury in mechanically ventilated patients with COVID-19-related septic shock: An exploratory analysis of non-renal organ dysfunction markers.

Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)·2026
Same author

Development of a nomogram for predicting kidney replacement therapy and hyperkalemia in acute kidney injury.

Nefrologia·2026
Same author

Beyond social media: the era of generative AI and intelligent digital platforms in nephrology education.

Renal failure·2026
Same journal

Pentoxifylline and cardiorenal outcomes in advanced CKD with untreated dyslipidemia: a longitudinal cohort study.

Renal failure·2026
Same journal

Risk factors and temporal trends of early urological complications after kidney transplantation: a 15-year single-center cohort study.

Renal failure·2026
Same journal

SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism.

Renal failure·2026
Same journal

Hypoxia-inducible factor-1α promotes epithelial-to-mesenchymal transition through upregulating cathepsin S expression in diabetic kidney disease.

Renal failure·2026
Same journal

Development and validation of a dual-channel deep learning for continuous acute kidney injury prediction in critically ill patients.

Renal failure·2026
Same journal

Relaxin inhibits renal interstitial fibrosis and promotes fatty acid metabolism after UUO <i>via</i> the AMPK/PGC1α signaling pathway.

Renal failure·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

335

Decrease in platelet count in patients with AKI and its association with major adverse kidney events.

Ramón Medina-González1, Jose J Zaragoza2, Eduardo M Hernández-Barajas1,3

  • 1Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.

Renal Failure
|June 13, 2024
PubMed
Summary
This summary is machine-generated.

A significant platelet reduction (>21%) in acute kidney injury (AKI) patients is linked to adverse kidney events within 10 days. This platelet drop also increases mortality risk, highlighting its role as a severity marker in AKI.

Keywords:
Acute kidney injuryhemodialysismajor adverse kidney eventsplateletsthrombocytopenia

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

833
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

Related Experiment Videos

Last Updated: Jun 24, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

335
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

833
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

Area of Science:

  • Nephrology
  • Hematology
  • Critical Care Medicine

Background:

  • Platelet reduction is a known severity marker in critically ill patients.
  • The association between platelet count and outcomes in acute kidney injury (AKI) remains unclear.

Purpose of the Study:

  • To investigate the relationship between a significant platelet reduction and major adverse kidney events (MAKE) in AKI patients.
  • To determine if platelet count changes predict mortality in AKI.

Main Methods:

  • Retrospective cohort study of 400 AKI patients.
  • Patients categorized by >21% platelet count reduction within 10 days.
  • Analysis of associations with MAKE at 10 days (MAKE10) and 30-90 days (MAKE30-90), and mortality.

Main Results:

  • A >21% platelet reduction was associated with MAKE10 (OR 4.2).
  • Increased mortality risk (OR 2.9) observed with platelet counts <90 x 10³ cells/µL.
  • Associations lost significance when accounting for hemodialysis initiation.

Conclusions:

  • A >21% platelet reduction in AKI patients is associated with MAKE.
  • Further research with robust designs is warranted to confirm these findings.